AdipoGen Life Sciences

anti-ANGPTL7 (human), mAb (Kairos 397-7)

As low as CHF 190.00
In stock
Only %1 left
AG-20A-0055-C100100 µgCHF 190.00

Specifications / Handling

More Information
Product Details
Synonyms Angiopoietin-like Protein 7; Cornea-derived Transcript 6 Protein
Product Type Monoclonal Antibody
Properties
Clone Kairos 397-7
Isotype Mouse IgG1κ
Immunogen/Antigen Recombinant human full length ANGPTL7.
Application

ELISA: (direct or indirect: 1:500-1:5'000)
Western blot: (1:500-1:5'000 using ECL. Suggested blocking and dilution buffer is PBST with 0.05% Tween 20 and 5% skim milk. Suggested incubation time is 1 hour at room temperature).
Optimal conditions should be determined individually for each application.

Note: Tested on recombinant proteins and/or target-protein transfected cell lines in ELISA, Western Blot and/or FACS.

Crossreactivity Human
Specificity

Recognizes human ANGPTL7. Detects a band of ~45kDa by Western blot. Weakly cross-reacts with the fibrinogen-like domain (FLD) of human ANGPTL7.

Purity Detail Protein G-affinity purified.
Concentration 1mg/ml
Formulation Liquid. 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.
Isotype Negative Control

Mouse IgG1 Isotype Control

Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice After opening, prepare aliquots and store at -20°C.
Avoid freeze/thaw cycles.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Documents
MSDS Download PDF Download PDF
Product Specification Sheet
Datasheet Download PDF Download PDF

Scientific Background Information

Product Description

ANGPTL7 is expressed in various tissues and regulates angiogenesis. Human ANGPTL7 was characterized as a potent target gene of the WNT/ beta-catenin signaling pathway, and is a pharmacogenomics target in the fields of oncology and regenerative medicine. Overexpression of ANGPTL7 increases collagen expression and might exert a pathogenic role in glaucoma.

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.